Comera Life Sciences Holdings, Inc.Comera Life Sciences Holdings, Inc.Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

No trades
See on Supercharts
Market capitalization
‪1.11 M‬USD
−0.4944USD
‪−18.00 M‬USD
‪633.10 K‬USD
‪4.35 M‬
Beta (1Y)
−2.16

About Comera Life Sciences Holdings, Inc.

CEO
Michael Campbell
Headquarters
Woburn
Employees (FY)
13
Founded
2022
FIGI
BBG017NL9C05
Comera Life Sciences Holdings, Inc. engages in developing medicines. It applies a deep knowledge of formulation science and technology to transform essential biologic medicines. The firm's approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen. The company was founded on January 31, 2022 and is headquartered in Woburn, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CMRA is 0.0361 USD — it has decreased by 11.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Comera Life Sciences Holdings, Inc. stocks are traded under the ticker CMRA.
CMRA stock is 90.70% volatile and has beta coefficient of −2.16. Check out the list of the most volatile stocks — is Comera Life Sciences Holdings, Inc. there?
Yes, you can track Comera Life Sciences Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
CMRA stock has fallen by 11.95% compared to the previous week, the month change is a 3.14% rise, over the last year Comera Life Sciences Holdings, Inc. has showed a 95.49% decrease.
CMRA net income for the last quarter is ‪−2.15 M‬ USD, while the quarter before that showed ‪−1.41 M‬ USD of net income which accounts for −52.57% change. Track more Comera Life Sciences Holdings, Inc. financial stats to get the full picture.
Today Comera Life Sciences Holdings, Inc. has the market capitalization of ‪1.11 M‬, it has decreased by 31.09% over the last week.
No, CMRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Comera Life Sciences Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CMRA reached its all-time high on May 10, 2022 with the price of 15.3000 USD, and its all-time low was 0.0300 USD and was reached on Nov 17, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 13.00 employees. See our rating of the largest employees — is Comera Life Sciences Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Comera Life Sciences Holdings, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Comera Life Sciences Holdings, Inc. stock shows the sell signal. See more of Comera Life Sciences Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Comera Life Sciences Holdings, Inc. EBITDA is ‪−9.07 M‬ USD, and current EBITDA margin is ‪−1.64 K‬%. See more stats in Comera Life Sciences Holdings, Inc. financial statements.